SuFEx Cyclization Enables DNA-Encoded Macrocyclic Peptide Libraries for Drug Discovery
Journal of the American Chemical Society · 04.11.2026 · 148 (43) · 46579-46592
DOI: 10.1021/jacs.6c07049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 11.09.2026. Verfasst von Tianxiong Mi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Discovery Chemistry, Merck & Co., Inc., Rahway, New Jersey07065, United States. Hauptthemen laut MEDLINE: DNA, Drug Discovery, Peptide Library, Macrocyclic Compounds. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Merck.
Abstract (Originalsprache)
Rapid, aqueous macrocyclization strategies that proceed in high conversion are valuable for ultralarge macrocyclic peptide (MP) library synthesis via display and DNA-encoded library (DEL) technology. Here we report an on-DNA macrocyclization based on sulfur(VI) fluoride exchange (SuFEx) that unites above features. This approach embeds a phenol and an aryl sulfonyl fluoride within a DNA-tagged peptide to accelerate SuFEx and trigger intramolecular cyclization immediately upon dissolution in basic aqueous buffer. MPs ranging from 15 to 52 membered rings bearing diverse amino acids were synthesized efficiently. The on-DNA conditions readily translate off DNA to furnish sulfonate and sulfonamide linked MPs. NMR analyses showed SuFEx-derived biaryl linkers act as conformational tuner: sequential changes in aryl substitution and linker length shift backbone conformations from extended strands to rigid turns. Leveraging this chemistry, we designed and synthesized ultralarge MP libraries via DEL technology. DEL screening followed by off-DNA hit validation identified a potent, de novo MP inhibitor of receptor-interacting serine/threonine kinase 1 (RIPK1). Collectively, these findings establish SuFEx cyclization as a robust, DEL-compatible strategy for programmable macrocycle design and drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Discovery Chemistry, Merck & Co., Inc., Rahway, New Jersey07065, United States.
- Quantitative Biosciences, Merck & Co., Inc., Rahway, New Jersey07065, United States.
- Pharmaceutical Analysis & Digital Technologies, Merck & Co., Inc., Rahway, New Jersey07065, United States.
- Modeling and Informatics, Merck & Co., Inc., Rahway, New Jersey07065, United States.
- Quantitative Biosciences, Merck & Co., Inc., Boston, Massachusetts02115, United States.
ORCID-Profile: Tianxiong Mi, Lijun Fan, Chang Qi, Errol L G Samuel, Qi Gao, Xingjian Xu, Erwin G Abucayon, Jordan De Jesus Silva, Jack D Scott
Förderung
- Merck
Zitieren
APA
Mi, T., Fan, L., Hackler, A., Diaz, D. B., Qi, C., Samuel, E. L. G., Gao, Q., Meng, T., Xu, X., Abucayon, E. G., DiNunzio, E. N., Murai, M. J., Pissarnitski, N., De Jesus Silva, J., Sondey, C., & Scott, J. D. (2026). SuFEx Cyclization Enables DNA-Encoded Macrocyclic Peptide Libraries for Drug Discovery. Journal of the American Chemical Society, 148(43), 46579-46592. https://doi.org/10.1021/jacs.6c07049
Vancouver
Mi T, Fan L, Hackler A, Diaz DB, Qi C, Samuel ELG, et al. SuFEx Cyclization Enables DNA-Encoded Macrocyclic Peptide Libraries for Drug Discovery. Journal of the American Chemical Society. 2026;148(43):46579-46592. doi:10.1021/jacs.6c07049
BibTeX
@article{Mi2026,
author = {Mi, Tianxiong and Fan, Lijun and Hackler, Amber and Diaz, Diego B and Qi, Chang and Samuel, Errol L G and Gao, Qi and Meng, Tao and Xu, Xingjian and Abucayon, Erwin G and DiNunzio, Edward N and Murai, Marcelo J and Pissarnitski, Natalya and De Jesus Silva, Jordan and Sondey, Christopher and Scott, Jack D},
title = {SuFEx Cyclization Enables DNA-Encoded Macrocyclic Peptide Libraries for Drug Discovery},
journal = {Journal of the American Chemical Society},
year = {2026},
volume = {148},
number = {43},
pages = {46579--46592},
doi = {10.1021/jacs.6c07049}
}
EUVIMED